Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from EMA

EU agency flags risks to nuclear medicines from dependency on Russia and US

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).

Euronews

EU regulators block new Alzheimer’s drug citing potentially fatal side effects

The company behind the drug donanemab said it will ask regulators to reconsider the decision.

Euronews

Addressing Challenges in Rare Disease Clinical Trials: Strategies for Success with iNGENū CRO

iNGENū CRO leverages global expertise, advanced technology, and strategic funding to overcome rare disease trial challenges.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Beware of unproven cancer treatments advertised online, EU medicine regulators say

The warning comes amid reports that unregulated therapies are being offered directly to patients, potentially illegally.

Euronews

3 High-Conviction Stocks with Strong Buy Ratings from Analysts

It’s easy to get caught up in market noise, but investing in companies backed by strong fundamentals and long-term growth potential can help investors stay the course even during market volatility. Thus, one could consider adding these three high-conviction pharmaceutical stocks, AbbVie (ABBV), Merck & Co. (MRK), and Bristol-Myers Squibb…

StockNews.com

3 Biotech Stocks With Promising Pipelines

The biotech sector’s AI-driven advancements, personalized medicine demand, and streamlined regulations fuel significant market growth. Hence, investors should consider robust biotech stocks such as Vertex Pharmaceuticals (VRTX), Amgen (AMGN), and Gilead Sciences (GILD). Read on.

StockNews.com

New Porsche team joins DTM in 2025, signs ex-Audi driver Feller

Porsche has announced that it will have an expanded presence in the DTM in 2025, with Allied Racing joining incumbent Manthey.

Motorsport

Read news from The Economist, FT, and more,
with one subscription

MTV EMAs to honor Busta Rhymes. Taylor is the leading nominee and Rita Ora is hosting

The MTV EMAs will honor hip-hop legend Busta Rhymes with its Global Icon Award Sunday

The Independent UK

Pharmaceutical Labeling Machines: Meeting Precision and Compliance Requirements In The Field

As the production process of medicine continues to evolve, pharmaceutical labeling machines have also become more advanced in their design and features. The importance of labeling machines does not end with applying a label on a bottle or box; they ensure accuracy, legal compliance, and the seamless packaging of drugs…

inkl

Donanemab – what we know about the latest Alzheimer’s drug

The drug is one of the new ‘disease modifying’ treatments for Alzheimer’s disease.

Evening Standard

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

The Independent UK

Report: Greg Norman Could Be Out as LIV Golf CEO, Yet Remain With the League

A search firm is looking for Norman's replacement to lead LIV Golf and among its preliminary calls was a college conference commissioner, who wasn't interested.

Sports Illustrated

Could Ozempic increase suicidal thoughts?

Researchers found cases of the obesity drug putting patients at greater risk of suicidal ideation.

Fortune

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

NICE says drug is not cost effective and shares fears of side effects

The Independent UK

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

Barchart

1 'Strong Buy' Small-Cap With 276% Upside Potential

As Jasper embarks on promising clinical trials and reports narrower losses, analysts remain bullish, setting ambitious price targets that could indicate substantial returns for investors.

Autosport

Nurburgring 24 Hours result upheld after Rowe Racing appeal fails

Rowe Racing's appeal against the result of the Nurburgring 24 Hour race has failed, ensuring Scherer Sport Phx drivers Christopher Mies, Dennis Marschall, Frank Stippler and Ricardo Feller remain victorious.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

EU drugs watchdog probes painkiller linked to deaths

Campaigner welcomes investigation into drug after hundreds of suspected adverse reactions

StockNews.com

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

Autosport

Lietz "had no idea" last-lap WEC Spa move was for LMGT3 victory

Lietz revealed that he at first "had no idea" about the significance of his pass on team-mate Klaus Bachler into Les Combes, which secured victory for the #91 Manthey EMA Porsche he shared with Yasser Shahin and Morris Schuring, as he had begun the final tour in third place.

Autosport

DTM 2024 entry list: Who is driving in the DTM this year?

A total of 20 drivers are competing in the DTM in 2024, representing nine teams and seven different manufacturers.

StockNews.com

Top Biotech 3 Stocks With Accelerating Profits

The biotechnology industry is booming thanks to growing demand for innovative healthcare solutions, favorable government initiatives, and several scientific breakthroughs. Thus, quality biotech stocks Genmab (GMAB), Halozyme Therapeutics (HALO), and Vertex Pharmaceuticals (VRTX) could be ideal buys for substantial profits. Read more….

StockNews.com

Top 4 Pharma Stocks on the Rise for Potential Gains

Growing medical needs, surging demand for precision medicine, favorable regulatory climate, and rapid digital transformation would create promising growth opportunities for pharma companies. Hence, it could be wise to invest in top pharma stocks Johnson & Johnson (JNJ), Spero Therapeutics (SPRO), Ipsen (IPSEY), and Procaps Group (PROC) for solid gains.…

Autosport

Supercars circuit owner to join WEC field in Manthey Porsche

Shahin and Morris Schuring will pair up with Manthey’s designated Pro driver Richard Lietz at the wheel of the #91 Porsche 911 GT3 R (Type 992) that will be run in collaboration with EMA in the new LMGT3 class.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.